Quintiles
From Wikipedia, the free encyclopedia
| Type | Public |
|---|---|
| Traded as | NYSE: Q |
| Industry |
Contract Research Organization Pharmaceutical Service Consulting |
| Founded | 1982 |
| Headquarters | Durham, North Carolina, USA |
| Key people |
Dennis Gillings, Executive Chairman Tom Pike CEO John Ratliff President & COO; Paula Brown Stafford, President Clinical |
| Products | Support services for pharmaceutical, biotech and medical companies and individuals |
| Revenue |
 US$ Approximately $3.7 billion |
| Employees | ~ 27,000+ (2013) |
| Website | http://www.quintiles.com/ |
Quintiles Transnational is the world’s largest provider of biopharmaceutical development and commercial outsourcing services with a network of more than 33,000 employees conducting business in approximately 100 countries. Quintiles has helped develop or commercialize all of the top-50 best-selling drugs on the market.[1]
History
Quintiles was founded in 1982 by Dennis Gillings, Ph.D., CBE, then a professor of biostatistics at the University of North Carolina, Chapel Hill.[2]
Key Dates:
- 1974: Dennis Gillings signs first contract to provide statistical and data management consulting for pharmaceutical clients.
- 1982: Quintiles, Inc., is incorporated in North Carolina.
- 1990: Quintiles Pacific Inc. and Quintiles Ireland Ltd. established
- 1991: Quintiles GMBH established in Germany; Quintiles Laboratories Ltd. established in Atlanta, Georgia
- 1996: Quintiles buys Innovex Ltd. and BRI International Inc., becoming the world's largest CRO[3]
- 1997: Quintiles goes public, completing successful secondary stock offering.
- 1998: Quintiles is the first company in industry to break the $1 billion mark, when it reports net revenues of $1.19 billion.
- 1999: Company joins the S&P 500 Index.
- 2003: Board of Directors agrees to merge with Pharma Services Holdings Inc; Quintiles becomes a private company.
- 2009: Quintiles opens new corporate headquarters in Durham, North Carolina
- 2010: Quintiles opens new European headquarters in the UK and establishes operations in East Africa.
- 2011: Quintiles buys Advion Biosciences, a bioanalytical lab based out of Ithaca, New York
- 2013: Quintiles files for an IPO on 15 February in order to go public again [4]
- 2013: Quintiles begins trading on the New York Stock Exchange (NYSE) under ticker symbol Q [5]
References
- ↑ B, Mrs F. "Interview with Quintiles France". Quintiles France. Expatriates Magazine Ed1.
- ↑ "Money, Math and Medicine". Forbes Magazine. November 22, 2010. Retrieved April 14, 2011.
- ↑ "High-Flying Quintiles to Buy Innovex in $747.5 Million Deal". New York Times. October 8, 1996. Retrieved April 14, 2011.
- ↑ http://www.sec.gov/Archives/edgar/data/1478242/000119312513062656/d483912ds1.htm
- ↑ Wall Street Journal, May 9, 2013
External links
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.